Shawver Laura's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Dec 4, 2024
- Accession no.
- 0001415889-24-028350
- Filed
- Dec 4, 2024
- Trade date
- Dec 2-4, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 5 derivative transactions. Open-market sales total $2.69M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shawver LauraCIK 0001551891 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | MOption exerciseAcquired | +67,616 | $1.27 | +$85,872.32 | 277,962 | Direct | |
| Dec 2, 2024 | Common Stock | MOption exerciseAcquired | +29,628 | $1.27 | +$37,627.56 | 307,590 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −96,343 | $13.55 | −$1,305,447.65 | 211,247 | Direct | |
| Dec 2, 2024 | Common Stock | SSaleDisposed | −901 | $14.34 | −$12,920.34 | 210,346 | Direct | |
| Dec 3, 2024 | Common Stock | MOption exerciseAcquired | +25,606 | $1.27 | +$32,519.62 | 235,952 | Direct | |
| Dec 3, 2024 | Common Stock | MOption exerciseAcquired | +62,378 | $3.15 | +$196,490.7 | 298,330 | Direct | |
| Dec 3, 2024 | Common Stock | SSaleDisposed | −87,984 | $13.26 | −$1,166,667.84 | 210,346 | Direct | |
| Dec 4, 2024 | Common Stock | MOption exerciseAcquired | +14,772 | $3.15 | +$46,531.8 | 225,118 | Direct | |
| Dec 4, 2024 | Common Stock | SSaleDisposed | −14,772 | $13.75 | −$203,115 | 210,346 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | MOption exerciseDisposed | −29,628 | $0.00 | $0 | 25,606 | Direct | |
| Dec 2, 2024 | Common Stock | MOption exerciseDisposed | −67,616 | $0.00 | $0 | 0 | Direct | |
| Dec 3, 2024 | Common Stock | MOption exerciseDisposed | −25,606 | $0.00 | $0 | 0 | Direct | |
| Dec 3, 2024 | Common Stock | MOption exerciseDisposed | −62,378 | $0.00 | $0 | 73,836 | Direct | |
| Dec 4, 2024 | Common Stock | MOption exerciseDisposed | −14,772 | $0.00 | $0 | 59,064 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.